Trinity Biotech (TRIB) Shareholders Approve 10% Buyback Plan
Tweet Send to a FriendGet Alerts TRIB Hot Sheet
Up)
Trade TRIB Now!
Trinity Biotech plc (Nasdaq: TRIB) shareholders approved the Company to repurchase its own shares, up to a maximum of 10% of the outstanding shares at the date of the meeting. This authority is valid for an 18 month period commencing on the date of the meeting and is capable of being renewed at any future General Meeting.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Elan Corp (ELN) Plans Strategic Change of Company; Proposes $200M Buyback
- Northrop Grumman (NOC) Adds $4B to Repurchase Plan, Plans to Retire 25% Outstanding Shares
Create E-mail Alert Related Categories
Stock Buybacks
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
